Metallic taste: An unusual reaction to botulinum toxin A

Dermatologic Surgery

Volumn 29, Issue 5, 2003, Pages 562-563

  Murray, Christian ^a,b   Solish, Nowell ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; DOSE RESPONSE; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; DYSGEUSIA; FACE MALFORMATION; FEMALE; HUMAN; PARALYSIS; PATHOGENESIS; PRIORITY JOURNAL; TASTE DISORDER; TREATMENT PLANNING; ZINC METABOLISM;

ADULT; BOTULINUM TOXIN TYPE A; FACE; FEMALE; HUMANS; NEUROMUSCULAR AGENTS; SKIN AGING; TASTE DISORDERS;

EID: 0037610879     PISSN: 10760512     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-4725.2003.29131.x     Document Type: Article

References (22)

1. Carruthers A, Carruthers J. Update on the botulin neurotoxins. Skin Ther Lett 2000;6:1-2.
2. Carruthers A, Carruthers J. History of the cosmetic use of botulinum A exotoxin. Dermatol Surg 1998;24:1168-70.
3. Mendez-Eastman SK. BOTOX: a review. Plast Surg Nuts 2000;20:60-5.
4. Matarasso A, Deva AK. The American Society of Plastic Surgeons DATA Committee: botulinum toxin. Plast Reconstr Surg 2002;109:1191-7.
5. O'Day J. Use of botulinum toxin in neuro-ophthalmology. Curr Opin Ophthalmol 2001;12:419-22.
6. Jozefczyk PB. The management of focal spasticity. Clin Neuropharmacol 2002;25:158-73.
7. Tintner R, Jankovic J. Focal dystonia: the role of botulinum toxin. Curr Neurol Neurosci Rep 2001;1:337-45.
8. Velickovic M, Benabou R, Brin MF. Cervical dystonia pathophysiology and treatment options. Drugs 2001;61:1921-43.
9. Tan S, Solish N. Long-term efficacy and quality of life in the treatment of focal hyperhidrosis with botulinum toxin A. Dermatol Surg 2002;28:495-9.
10. Atkins JL, Butler PE. Hyperhidrosis: a review of current management. Plast Reconstr Surg 2002;110:222-8.
11. Glogau R. Treatment of palmar hyperhidrosis with botulinum toxin. Semin Cutan Med Surg 2001;20:101-8.
12. Gobel H, Heinze A, Heinze-Kuhn K, Jost WH. Evidence-based medicine: botulinum toxin A in migraine and tension-type headache. J Neurol 2001;248:34-8.
13. Diener HC, Limmroth V. Advances in pharmacological treatment of migraine. Expert Opin Invest Drugs 2001;10:1831-45.
14. Carruthers J, Carruthers A. BOTOX use in the mid and lower face and neck. Semin Cutan Med Surg 2001;20:85-92.
15. Klein AW. Complications and adverse reactions with the use of botulinum toxin. Semin Cutan Med Surg 2001;20:109-20.
16. Carruthers J, Lowe N, Mentor A, et al. A multicenter, double blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines. J Am Acad Dermatol 2002;46:840-9.
17. Ackerman B, Kasbekar N. Disturbances of taste and smell induced by drugs. Pharmacotherapy 1997;17:482-96.
18. Henkin R. Drug induced taste and smell disorders. Drug Safety 1994;11:318-77.
19. Johnson FM. Alterations in taste sensation: a case presentation of a patient with end-stage pancreatic cancer. Cancer Nurs 2001;24:149-55.
20. Griffin J. Drug induced taste disorders. Adverse Drug React Toxicol 1992;11:229-39.
21. Frank ME, Hettinger TP, Mott AE. The sense of taste: neurobiology, aging, and medication effects. Crit Rev Oral Biol Med 1992;3:371-93.
22. Hambleton P. Clostridium botulinum toxins: a general review of involvement in disease, structure, mode of action and preparation for clinical use. J Neurol 1992;239:16-20.